<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00913523</url>
  </required_header>
  <id_info>
    <org_study_id>2007-101</org_study_id>
    <nct_id>NCT00913523</nct_id>
  </id_info>
  <brief_title>Clinical Evaluation of Effects of an Investigational Tampon on Vaginal Microflora</brief_title>
  <official_title>Vaginal Lactobacillus and Other Key Microflora During and After Menses in Women Using Tampons Containing Glycerol Monolaurate (GML) and Women Using Tampons Without GML</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johnson &amp; Johnson Consumer and Personal Products Worldwide</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johnson &amp; Johnson Consumer and Personal Products Worldwide</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Subjects will be using investigational or control tampons during their menstrual period but
      these tampons are not intended to prevent, treat or diagnose an infection or other disease
      condition. A total 450 women will participate in this study at two study sites. Subjects will
      be randomly assigned to one of three tampon groups. The first group will test an experimental
      test tampon containing glycerol monolaurate (GML) on the cover. The second group will test an
      identical tampon, but without GML. The third group will not be issued study tampons but will
      be instructed to use their normal tampon brand. This study is intended to determine whether
      the effects of GML observed in the laboratory can be demonstrated in healthy menstruating
      women.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects will be using investigational or control tampons during their menstrual period but
      these tampons are not intended to prevent, treat or diagnose an infection or other disease
      condition. This study will be a randomized, single-blinded, multi-center study of women using
      Tampons with GML, Tampons without GML or the Tampons Normally Used for one menstrual period.
      Subjects will undergo Baseline microflora evaluations taken from the vaginal walls 5-10 days
      following their menstrual period (Baseline evaluation). Subjects will be randomly assigned to
      use one of the three study products during their next menstrual period. Microflora will be
      re-evaluated in samples taken from the tampons and from the vaginal walls during use of the
      study tampons, and from vaginal walls soon after the end of the menstrual period. Evaluations
      of microflora will be done by quantitative cultures of tampons and vaginal swabs, and also by
      Nugent scoring of the vaginal swabs. Staphylococcal Î±-hemolysin and TSST-1 will be analyzed
      in extracts of the study tampons from subjects found to be colonized with S. aureus. Vaginal
      pH will be measured, using electronic meters, at each clinic visit. All samples (tampons and
      vaginal swabs) will be analyzed at a central microbiology laboratory. Extracts of tampons
      found to contain S. aureus will be forwarded to another central laboratory for the toxin
      assays. Personnel in the central laboratories will be blinded to the group assignment (study
      product) for each subject until completion of the study.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2009</start_date>
  <completion_date type="Actual">August 2009</completion_date>
  <primary_completion_date type="Actual">August 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of Subjects Showing Unfavorable Changes in Primary Microflora</measure>
    <time_frame>Mid-Cycle Baseline to Mid-Menstrual Samples</time_frame>
    <description>Percentage of subjects showing unfavorable changes of at least 1-log in lactobacilli (decrease), C. albicans (increase), or G. vaginalis (increase)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of Subjects Showing Unfavorable Changes in Primary Microflora</measure>
    <time_frame>Mid-Cycle Baseline to Post-Menstrual Samples</time_frame>
    <description>Percentage of subjects showing unfavorable changes of at least 1-log in lactobacilli (decrease), C. albicans (increase), or G. vaginalis (increase)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Subjects With Selected Microflora in Tampons</measure>
    <time_frame>During Menses</time_frame>
    <description>Percentage of subjects with selected relevant microorganisms in tampons during menses</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Abundance of Selected Microflora in Tampons</measure>
    <time_frame>During Menses</time_frame>
    <description>Abundance of selected relevant microorganisms in tampons during menses, in log10 colony forming units (CFU) per gram of menstrual fluid add-on to the tampon, in subjects who had detectable counts of the microorganism.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Nugent Score</measure>
    <time_frame>Mid-Cycle Baseline to Mid-Menstrual Samples</time_frame>
    <description>Percentage of subjects who showed a change in Nugent score from a score of &lt;/= 3 to a score of &gt;/= 4.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Nugent Score</measure>
    <time_frame>Mid-Cycle Baseline to Post-Menstrual Samples</time_frame>
    <description>Percentage of subjects who showed a change in Nugent score from a score of &lt;/= 3 to a score of &gt;/= 4.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">482</enrollment>
  <condition>Vaginal Microflora</condition>
  <arm_group>
    <arm_group_label>Tampon with GML</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Regular and Super Tampon with GML added to the cover</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tampon without GML</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Regular and Super Tampon without GML</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tampon Normally Used</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Type and Size of Tampon Normally Used by Subjects</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Experimental - Tampon with GML</intervention_name>
    <description>Regular and Super Tampon with Glycerol Monolaurate (GML) added to the cover</description>
    <arm_group_label>Tampon with GML</arm_group_label>
    <other_name>Not yet marketed</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham Control - Tampons without GML</intervention_name>
    <description>There is no intervention associated with these arms - they are sham controls.</description>
    <arm_group_label>Tampon without GML</arm_group_label>
    <arm_group_label>Tampon Normally Used</arm_group_label>
    <other_name>Tampons with no GML</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  normal healthy women

          -  18-45 years of age

          -  regular 21- to 35-day menstrual cycles with at least 5 days of bleeding, or at least 3
             days of bleeding if they are using hormonal contraception

          -  used tampons as their principal mode of menstrual sanitary protection for at least the
             previous 6 months

          -  willing to not change their feminine care or hygiene practices during their
             participation in the study (except as directed by the protocol and instructions for
             participants)

        Exclusion Criteria:

          -  signs or symptoms of clinically significant vulvovaginal infection or vaginosis

          -  history of recurrent urinary tract or vulvovaginal infection

          -  abnormal vaginal discharge of any etiology

          -  use of a systemic, vaginal, or perineal antibiotic, antifungal, anti-infective, or
             immunosuppressant medication or any experimental drug or medical device within the 30
             days preceding the Screening/Baseline Visit

          -  history of treatment for Toxic Shock Syndrome (TSS) or a suspicion of having had TSS

          -  other clinical issues or history (per protocol) that would make participation in the
             trial inappropriate
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David J Chase, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Johnson &amp; Johnson Consumer and Personal Products Worldwide</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hill Top Research</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85251</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hill Top Research</name>
      <address>
        <city>St. Petersburg</city>
        <state>Florida</state>
        <zip>33710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 3, 2009</study_first_submitted>
  <study_first_submitted_qc>June 3, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 4, 2009</study_first_posted>
  <results_first_submitted>April 12, 2011</results_first_submitted>
  <results_first_submitted_qc>April 12, 2011</results_first_submitted_qc>
  <results_first_posted type="Estimate">May 6, 2011</results_first_posted>
  <last_update_submitted>August 19, 2011</last_update_submitted>
  <last_update_submitted_qc>August 19, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 23, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>tampons</keyword>
  <keyword>Glycerol Monolaurate</keyword>
  <keyword>vaginal microflora</keyword>
  <keyword>microbes</keyword>
  <keyword>Vaginal Tampon</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glycerol</mesh_term>
    <mesh_term>Monolaurin</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Tampon With GML</title>
          <description>Regular and Super Tampon with GML added to the cover</description>
        </group>
        <group group_id="P2">
          <title>Tampon Without GML</title>
          <description>Regular and Super Tampon without GML added to the cover</description>
        </group>
        <group group_id="P3">
          <title>Tampon Normally Used</title>
          <description>Type and Size of Tampon Normally Used by Subjects</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="162"/>
                <participants group_id="P2" count="159"/>
                <participants group_id="P3" count="161"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="144"/>
                <participants group_id="P2" count="143"/>
                <participants group_id="P3" count="147"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="18"/>
                <participants group_id="P2" count="16"/>
                <participants group_id="P3" count="14"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="8"/>
                <participants group_id="P3" count="8"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Pregnancy</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Inadequate Number of Tampons Used</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Tampon With GML</title>
          <description>Regular and Super Tampon with GML added to the cover</description>
        </group>
        <group group_id="B2">
          <title>Tampon Without GML</title>
          <description>Regular and Super Tampon without GML added to the cover</description>
        </group>
        <group group_id="B3">
          <title>Tampon Normally Used</title>
          <description>Type and Size of Tampon Normally Used by Subjects</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="162"/>
            <count group_id="B2" value="159"/>
            <count group_id="B3" value="161"/>
            <count group_id="B4" value="482"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>18 to 64 years, inclusive</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="162"/>
                    <measurement group_id="B2" value="159"/>
                    <measurement group_id="B3" value="161"/>
                    <measurement group_id="B4" value="482"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="162"/>
                    <measurement group_id="B2" value="159"/>
                    <measurement group_id="B3" value="161"/>
                    <measurement group_id="B4" value="482"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Hispanic or Latino (H/L)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="13"/>
                    <measurement group_id="B4" value="46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Not Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="140"/>
                    <measurement group_id="B2" value="142"/>
                    <measurement group_id="B3" value="148"/>
                    <measurement group_id="B4" value="430"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native Hawaiian/Other Pacific Islander (NH/OPI)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>H/L &amp; NH/OPI</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>American Indian or Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="21"/>
                    <measurement group_id="B4" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="141"/>
                    <measurement group_id="B2" value="138"/>
                    <measurement group_id="B3" value="133"/>
                    <measurement group_id="B4" value="412"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="162"/>
                    <measurement group_id="B2" value="159"/>
                    <measurement group_id="B3" value="161"/>
                    <measurement group_id="B4" value="482"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight 39-169 kg, inclusive</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="162"/>
                    <measurement group_id="B2" value="159"/>
                    <measurement group_id="B3" value="161"/>
                    <measurement group_id="B4" value="482"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Height 143-148 cm, inclusive</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="162"/>
                    <measurement group_id="B2" value="159"/>
                    <measurement group_id="B3" value="161"/>
                    <measurement group_id="B4" value="482"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index 15-54, inclusive</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="162"/>
                    <measurement group_id="B2" value="159"/>
                    <measurement group_id="B3" value="161"/>
                    <measurement group_id="B4" value="482"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Average Cycle 17-35 Days, inclusive</title>
          <description>Average Days per Cycle in the past 4-6 months</description>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="162"/>
                    <measurement group_id="B2" value="159"/>
                    <measurement group_id="B3" value="161"/>
                    <measurement group_id="B4" value="482"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Average Flow 3-10 Days, inclusive</title>
          <description>Average Days of Flow in the past 4-6 months</description>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Less than 3 Days</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 to 10 Days, inclusive</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="162"/>
                    <measurement group_id="B2" value="159"/>
                    <measurement group_id="B3" value="161"/>
                    <measurement group_id="B4" value="482"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>More than 10 Days</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Number of Pregnancies Less than 14</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="162"/>
                    <measurement group_id="B2" value="159"/>
                    <measurement group_id="B3" value="161"/>
                    <measurement group_id="B4" value="482"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Years of Tampon Use</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Less than 1 Year</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 Year</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 to 34 Years, inclusive</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="161"/>
                    <measurement group_id="B2" value="158"/>
                    <measurement group_id="B3" value="160"/>
                    <measurement group_id="B4" value="479"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Subjects Showing Unfavorable Changes in Primary Microflora</title>
        <description>Percentage of subjects showing unfavorable changes of at least 1-log in lactobacilli (decrease), C. albicans (increase), or G. vaginalis (increase)</description>
        <time_frame>Mid-Cycle Baseline to Mid-Menstrual Samples</time_frame>
        <population>Microbiological analyses are for the âper protocolâ population, and no data imputation was performed. Analysis was limited to those subjects whose samples were viable for culture upon receipt at the laboratory.</population>
        <group_list>
          <group group_id="O1">
            <title>Tampon With GML</title>
            <description>Regular and Super Tampon with GML added to the cover</description>
          </group>
          <group group_id="O2">
            <title>Tampon Without GML</title>
            <description>Regular and Super Tampon without GML added to the cover</description>
          </group>
          <group group_id="O3">
            <title>Tampon Normally Used</title>
            <description>Type and Size of Tampon Normally Used by Subjects</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Subjects Showing Unfavorable Changes in Primary Microflora</title>
          <description>Percentage of subjects showing unfavorable changes of at least 1-log in lactobacilli (decrease), C. albicans (increase), or G. vaginalis (increase)</description>
          <population>Microbiological analyses are for the âper protocolâ population, and no data imputation was performed. Analysis was limited to those subjects whose samples were viable for culture upon receipt at the laboratory.</population>
          <units>Percentage of Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="129"/>
                <count group_id="O2" value="140"/>
                <count group_id="O3" value="141"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="52.7"/>
                    <measurement group_id="O2" value="52.9"/>
                    <measurement group_id="O3" value="60.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Subjects Showing Unfavorable Changes in Primary Microflora</title>
        <description>Percentage of subjects showing unfavorable changes of at least 1-log in lactobacilli (decrease), C. albicans (increase), or G. vaginalis (increase)</description>
        <time_frame>Mid-Cycle Baseline to Post-Menstrual Samples</time_frame>
        <population>Microbiological analyses are for the âper protocolâ population, and no data imputation was performed. Analysis was limited to those subjects whose samples were viable for culture upon receipt at the laboratory.</population>
        <group_list>
          <group group_id="O1">
            <title>Tampon With GML</title>
            <description>Regular and Super Tampon with GML added to the cover</description>
          </group>
          <group group_id="O2">
            <title>Tampon Without GML</title>
            <description>Regular and Super Tampon without GML added to the cover</description>
          </group>
          <group group_id="O3">
            <title>Tampon Normally Used</title>
            <description>Type and Size of Tampon Normally Used by Subjects</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Subjects Showing Unfavorable Changes in Primary Microflora</title>
          <description>Percentage of subjects showing unfavorable changes of at least 1-log in lactobacilli (decrease), C. albicans (increase), or G. vaginalis (increase)</description>
          <population>Microbiological analyses are for the âper protocolâ population, and no data imputation was performed. Analysis was limited to those subjects whose samples were viable for culture upon receipt at the laboratory.</population>
          <units>Percentage of Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="136"/>
                <count group_id="O2" value="140"/>
                <count group_id="O3" value="141"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31.6"/>
                    <measurement group_id="O2" value="34.3"/>
                    <measurement group_id="O3" value="36.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Subjects With Selected Microflora in Tampons</title>
        <description>Percentage of subjects with selected relevant microorganisms in tampons during menses</description>
        <time_frame>During Menses</time_frame>
        <population>Microbiological analyses are for the âper protocolâ population, and no data imputation was performed. Analysis was limited to those subjects whose samples were viable for culture upon receipt at the laboratory.</population>
        <group_list>
          <group group_id="O1">
            <title>Tampon With GML</title>
            <description>Regular and Super Tampon with GML added to the cover</description>
          </group>
          <group group_id="O2">
            <title>Tampon Without GML</title>
            <description>Regular and Super Tampon without GML added to the cover</description>
          </group>
          <group group_id="O3">
            <title>Tampon Normally Used</title>
            <description>Type and Size of Tampon Normally Used by Subjects</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Subjects With Selected Microflora in Tampons</title>
          <description>Percentage of subjects with selected relevant microorganisms in tampons during menses</description>
          <population>Microbiological analyses are for the âper protocolâ population, and no data imputation was performed. Analysis was limited to those subjects whose samples were viable for culture upon receipt at the laboratory.</population>
          <units>Percentage of Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="130"/>
                <count group_id="O2" value="140"/>
                <count group_id="O3" value="141"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Lactobacilli</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89.2"/>
                    <measurement group_id="O2" value="85.0"/>
                    <measurement group_id="O3" value="85.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C. albicans</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.2"/>
                    <measurement group_id="O2" value="12.1"/>
                    <measurement group_id="O3" value="19.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>G. vaginalis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.7"/>
                    <measurement group_id="O2" value="43.6"/>
                    <measurement group_id="O3" value="46.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>E. coli</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.5"/>
                    <measurement group_id="O2" value="41.4"/>
                    <measurement group_id="O3" value="34.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Staphylococcus aureus</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.3"/>
                    <measurement group_id="O2" value="17.9"/>
                    <measurement group_id="O3" value="13.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Group B Streptococcus</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.9"/>
                    <measurement group_id="O2" value="22.1"/>
                    <measurement group_id="O3" value="25.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Enterococcus sp.</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46.2"/>
                    <measurement group_id="O2" value="37.9"/>
                    <measurement group_id="O3" value="40.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Abundance of Selected Microflora in Tampons</title>
        <description>Abundance of selected relevant microorganisms in tampons during menses, in log10 colony forming units (CFU) per gram of menstrual fluid add-on to the tampon, in subjects who had detectable counts of the microorganism.</description>
        <time_frame>During Menses</time_frame>
        <population>Microbiological analyses are for the âper protocolâ population, and no data imputation was performed. Analysis was limited to those subjects whose samples were viable for culture upon receipt at the laboratory.</population>
        <group_list>
          <group group_id="O1">
            <title>Tampon With GML</title>
            <description>Regular and Super Tampon with GML added to the cover</description>
          </group>
          <group group_id="O2">
            <title>Tampon Without GML</title>
            <description>Regular and Super Tampon without GML added to the cover</description>
          </group>
          <group group_id="O3">
            <title>Tampon Normally Used</title>
            <description>Type and Size of Tampon Normally Used by Subjects</description>
          </group>
        </group_list>
        <measure>
          <title>Abundance of Selected Microflora in Tampons</title>
          <description>Abundance of selected relevant microorganisms in tampons during menses, in log10 colony forming units (CFU) per gram of menstrual fluid add-on to the tampon, in subjects who had detectable counts of the microorganism.</description>
          <population>Microbiological analyses are for the âper protocolâ population, and no data imputation was performed. Analysis was limited to those subjects whose samples were viable for culture upon receipt at the laboratory.</population>
          <units>CFU/gm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="130"/>
                <count group_id="O2" value="140"/>
                <count group_id="O3" value="141"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Lactobacilli</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.5" spread="1.4"/>
                    <measurement group_id="O2" value="6.0" spread="1.2"/>
                    <measurement group_id="O3" value="6.0" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C. albicans</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.3" spread="1.3"/>
                    <measurement group_id="O2" value="3.7" spread="1.9"/>
                    <measurement group_id="O3" value="3.9" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>G. vaginalis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.2" spread="1.5"/>
                    <measurement group_id="O2" value="6.6" spread="1.2"/>
                    <measurement group_id="O3" value="6.3" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>E. coli</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.8" spread="1.9"/>
                    <measurement group_id="O2" value="4.7" spread="2.0"/>
                    <measurement group_id="O3" value="5.1" spread="2.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Staphylococcus aureus</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.6" spread="1.9"/>
                    <measurement group_id="O2" value="4.8" spread="1.7"/>
                    <measurement group_id="O3" value="4.7" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Group B Streptococcus</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.6" spread="1.7"/>
                    <measurement group_id="O2" value="6.9" spread="1.2"/>
                    <measurement group_id="O3" value="6.7" spread="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Enterococcus sp.</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.1" spread="1.5"/>
                    <measurement group_id="O2" value="5.0" spread="1.4"/>
                    <measurement group_id="O3" value="5.3" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Changes in Nugent Score</title>
        <description>Percentage of subjects who showed a change in Nugent score from a score of &lt;/= 3 to a score of &gt;/= 4.</description>
        <time_frame>Mid-Cycle Baseline to Mid-Menstrual Samples</time_frame>
        <population>Microbiological analyses are for the âper protocolâ population, and no data imputation was performed. Analysis was limited to those subjects whose samples were viable for culture upon receipt at the laboratory.</population>
        <group_list>
          <group group_id="O1">
            <title>Tampon With GML</title>
            <description>Regular and Super Tampon with GML added to the cover</description>
          </group>
          <group group_id="O2">
            <title>Tampon Without GML</title>
            <description>Regular and Super Tampon without GML added to the cover</description>
          </group>
          <group group_id="O3">
            <title>Tampon Normally Used</title>
            <description>Type and Size of Tampon Normally Used by Subjects</description>
          </group>
        </group_list>
        <measure>
          <title>Changes in Nugent Score</title>
          <description>Percentage of subjects who showed a change in Nugent score from a score of &lt;/= 3 to a score of &gt;/= 4.</description>
          <population>Microbiological analyses are for the âper protocolâ population, and no data imputation was performed. Analysis was limited to those subjects whose samples were viable for culture upon receipt at the laboratory.</population>
          <units>Percentage of Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="129"/>
                <count group_id="O2" value="140"/>
                <count group_id="O3" value="141"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.7"/>
                    <measurement group_id="O2" value="19.3"/>
                    <measurement group_id="O3" value="24.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Changes in Nugent Score</title>
        <description>Percentage of subjects who showed a change in Nugent score from a score of &lt;/= 3 to a score of &gt;/= 4.</description>
        <time_frame>Mid-Cycle Baseline to Post-Menstrual Samples</time_frame>
        <population>Microbiological analyses are for the âper protocolâ population, and no data imputation was performed. Analysis was limited to those subjects whose samples were viable for culture upon receipt at the laboratory.</population>
        <group_list>
          <group group_id="O1">
            <title>Tampon With GML</title>
            <description>Regular and Super Tampon with GML added to the cover</description>
          </group>
          <group group_id="O2">
            <title>Tampon Without GML</title>
            <description>Regular and Super Tampon without GML added to the cover</description>
          </group>
          <group group_id="O3">
            <title>Tampon Normally Used</title>
            <description>Type and Size of Tampon Normally Used by Subjects</description>
          </group>
        </group_list>
        <measure>
          <title>Changes in Nugent Score</title>
          <description>Percentage of subjects who showed a change in Nugent score from a score of &lt;/= 3 to a score of &gt;/= 4.</description>
          <population>Microbiological analyses are for the âper protocolâ population, and no data imputation was performed. Analysis was limited to those subjects whose samples were viable for culture upon receipt at the laboratory.</population>
          <units>Percentage of Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="136"/>
                <count group_id="O2" value="140"/>
                <count group_id="O3" value="141"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.9"/>
                    <measurement group_id="O2" value="12.9"/>
                    <measurement group_id="O3" value="10.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Up to 35 days</time_frame>
      <desc>One Menstrual Cycle</desc>
      <group_list>
        <group group_id="E1">
          <title>Tampon With GML</title>
          <description>Regular and Super Tampon with GML added to the cover</description>
        </group>
        <group group_id="E2">
          <title>Tampon Without GML</title>
          <description>Regular and Super Tampon without GML added to the cover</description>
        </group>
        <group group_id="E3">
          <title>Tampon Normally Used</title>
          <description>Type and Size of Tampon Normally Used by Subjects</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="162"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="159"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="161"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Pregnancy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="162"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="159"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="161"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="162"/>
                <counts group_id="E2" subjects_affected="17" subjects_at_risk="159"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="161"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Gastrointestinal Discomfort</sub_title>
                <description>Includes diarrhea and bloating</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="162"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="159"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="161"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Dental Pain or Procedure</sub_title>
                <description>Includes tooth extraction, orthodontic pain, gum pain, dental pain</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="162"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="159"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="161"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Injuries</sub_title>
                <description>Includes injured knee, cut ankles, muscle tension, swollen legs</description>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="162"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="159"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="161"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Nervous System Discomfort</sub_title>
                <description>Includes headache, tension headache, anxiety, emotional stress</description>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="162"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="159"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="161"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Reproductive System Discomfort</sub_title>
                <description>Includes vaginal itching, dryness, irritation, odor, burning, light period, short period, heavy menstrual cramps, uterine infection, perineal irritation, groin irritation, abnormal pap smear, precancerous breast tissue, continual spotting</description>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="162"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="159"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="161"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Upper Respiratory Discomfort</sub_title>
                <description>Includes common cold, bronchitis, cough, head/sinus congestion/infection, upper respiratory infection, itching of the ears, laryngitis</description>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="162"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="159"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="161"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>No paper that incorporates Sponsor Confidential Information will be submitted for publication without Sponsor's prior written consent. The Institution will provide Sponsor with at least sixty (60) days for review of a manuscript, and if requested in writing, the Institution and Principal Investigators will withhold such publication for up to an additional sixty (60) days to allow for filing of a patent application.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Joyce Hauze, RPS Senior Specialist, Clinical Research Operations</name_or_title>
      <organization>Johnson &amp; Johnson Consumer and Personal Products Worldwide</organization>
      <phone>928-277-0715</phone>
      <email>jhauze@its.jnj.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

